Nicholas Investment Partners, LP
Source: SEC Form 13F · as of Mar 2026Nicholas Investment Partners, LP holds 18 biotech & pharma companies tracked by BioSniper, totaling $173.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$173.5M
BioSniper AIPage evidence connected
Prepared research question
What matters most for INSMED Inc (INSM)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| INSMINSMED Inc | 182,540 | $29.8M |
| RVMDREVOLUTION MEDICINES, INC. | 261,166 | $25.4M |
| BBIOBridgeBio Pharma, Inc. | 298,909 | $22.2M |
| NUVLNuvalent, Inc. | 159,721 | $16.4M |
| AXSMAxsome Therapeutics, Inc. | 81,478 | $13.8M |
| APGEApogee Therapeutics, Inc. | 130,992 | $11.0M |
| ABVXAbivax SA | 90,206 | $10.0M |
| ROIVRoivant Sciences Ltd. | 278,425 | $7.7M |
| ELVNEnliven Therapeutics, Inc. | 182,728 | $7.2M |
| CYTKCYTOKINETICS INC | 69,845 | $4.6M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 51,250 | $4.3M |
| SRRKScholar Rock Holding Corp | 82,511 | $4.1M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 125,136 | $4.0M |
| COGTCogent Biosciences, Inc. | 95,160 | $3.7M |
| PVLAPALVELLA THERAPEUTICS, INC. | 27,603 | $3.4M |
| VRDNViridian Therapeutics, Inc.\DE | 124,257 | $2.4M |
| ARGXARGENX SE | 2,898 | $2.1M |
| TERNTerns Pharmaceuticals, Inc. | 25,147 | $1.3M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.